Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Journal of Neurophysiology|August 22, 2014
Differential contribution of Kv4-containing channels to A-type, voltage-gated potassium currents in somatic and visceral dorsal root ganglion neuronsTakakazu Yunoki, Koichi Takimoto, Kaori Kita, et al.
Life Sciences|July 24, 2012
Distinct cellular distributions of Kv4 pore-forming and auxiliary subunits in rat dorsal root ganglion neuronsHiroko Matsuyoshi, Koichi Takimoto, Takakazu Yunoki, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|December 12, 2007
Comparative studies of ZD0947, a novel ATP-sensitive K(+) channel opener, on guinea pig detrusor and aortic smooth musclesTakakazu Yunoki, Hai-Lei Zhu, Kazuomi Iwasa, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|March 5, 2010
Effects of bladder outlet obstruction on properties of Ca2+-activated K+ channels in rat bladderMasafumi Kita, Takakazu Yunoki, Koichi Takimoto, et al.
European Journal of Pharmacology|December 14, 2004
Effects of U-37883A on intracellular Ca2+ -activated large-conductance K+ channels in pig proximal urethral myocytesNoriyoshi Teramoto, Manami Aishima, Hai-Lei Zhu, et al.
Cancer Chemotherapy and Pharmacology|May 23, 2019
Efficacy and safety of 4-weekly cabazitaxel for castration-resistant prostate cancer: a multi-institutional studyMasaki Shiota, Motonobu Nakamura, Akira Yokomizo, et al.
Anticancer Research|August 2, 2019
Therapeutic Outcome of >10 Cycles of Cabazitaxel for Castration-resistant Prostate Cancer: A Multi-institutional StudyMasaki Shiota, Motonobu Nakamura, Akira Yokomizo, et al.
Medical Oncology (Northwood, London, England)|March 1, 2019
Efficacy and safety of cabazitaxel for castration-resistant prostate cancer in patients with > 10 cycles of docetaxel chemotherapy: a multi-institutional studyMasaki Shiota, Motonobu Nakamura, Akira Yokomizo, et al.
Anticancer Research|January 2, 2020
Prognostic Impact of Prior Androgen Receptor Axis-targeting Agents in Cabazitaxel Chemotherapy After DocetaxelMasaki Shiota, Motonobu Nakamura, Akira Yokomizo, et al.
Anti-Cancer Drugs|January 9, 2020
Prognostic significance of lactate dehydrogenase in cabazitaxel chemotherapy for castration-resistant prostate cancer: a multi-institutional studyMasaki Shiota, Motonobu Nakamura, Akira Yokomizo, et al.
Pageof 3